Despite its strength in pharmaceuticals and biotechnology, the United States faces manufacturing challenges, including dependence on China for key inputs, which the National Security Commission on ...

Many might assume that over-the-counter (OTC) medications are generally safer than stronger prescription drugs, but research shows they can still present risks for some. "This is because they reduce ...

After months of threats, President Trump eased up pressure on drugmakers late last year. That’s all it took for investors to notice that the beaten-down sector was actually growing just fine. Talk of ...

An announcement from Nasus Pharma Ltd. ( (NSRX)) is now available. On December 22, 2025, Nasus Pharma Ltd. released a shareholder letter from CEO Dan Teleman highlighting a transformational year ...

LONDON, Dec 11 (Reuters) - Zealand Pharma (ZELA.CO), opens new tab plans to launch five obesity and related drugs by 2030 as the Danish company tries to break into the lucrative weight-loss market ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — European policymakers on Thursday unveiled a compromise ...

For pharmaceutical firms, watching the lucrative patents on their top-selling drugs expire has long been part of the business cycle. There’s enormous pressure to find ways of covering the shortfall.

A year ago, I was one of the top spokespeople for the pharmaceutical industry as the chief public affairs officer for the Biotechnology Innovation Organization. It was there I'd spent years creating ...

Please provide your email address to receive an email when new articles are posted on . Change in hemoglobin did not differ between patients taking NSAIDs before TJA and those who stopped NSAID use.

AFTER AMERICA, China is the world’s largest developer of new medicines. Its companies ran nearly a third of the planet’s clinical trials last year. That is up from just 5% a decade before (see chart 1 ...